Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Clinical and Experimental Dermatology
|
March 25, 2026
Changes in Drug Survival of Adalimumab Over Time in Patients with Psoriasis - A Nationwide Cohort Study
Gustav Hjort, Christopher W Schwarz, Lars E Bryld, et al.
International Journal of Molecular Sciences
|
April 13, 2023
Blood Cell Biomarkers of Inflammation and Cytokine Levels as Predictors of Response to Biologics in Patients with Psoriasis
Clara Sophie Bramsen Andersen, Amanda Kvist-Hansen, Mie Siewertsen, et al.
The Journal of Infectious Diseases
|
September 13, 2022
Incidence, Risk Factors, and Consequences of Human Alphaherpesvirus Infections in Patients With Psoriasis Who Initiate Methotrexate or Biologic Agents
Omid Rezahosseini, Mie Sylow Liljendahl, Nikolai Loft, et al.
JAMA Dermatology
|
January 7, 2026
Drug Survival of Biologics in Bionaive and Bioexperienced Patients With Psoriasis
Christopher Willy Schwarz, Nikolai Loft, Lars Erik Bryld, et al.
American Journal of Clinical Dermatology
|
March 5, 2025
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis
Amalie Thorsti Møller Rønnstad, Christopher G Bunick, Raj Chovatiya, et al.
American Journal of Clinical Dermatology
|
November 26, 2025
Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis
Amalie Thorsti Møller Rønnstad, Daniel Isufi, Christopher G Bunick, et al.
Acta Dermato-Venereologica
|
August 18, 2025
Adverse Events and Immune Response in Psoriasis Patients Receiving Interleukin-17 Inhibitors
Christopher Willy Schwarz, Charlotte Näslund-Koch, Claus Zachariae, et al.
Journal of the American Academy of Dermatology
|
November 30, 2020
Bidirectional association between atopic dermatitis, conjunctivitis, and other ocular surface diseases: A systematic review and meta-analysis
Nina H Ravn, Zohra F Ahmadzay, Tine A Christensen, et al.
The Journal of Allergy and Clinical Immunology
|
December 26, 2022
Skin TARC/CCL17 increase precedes the development of childhood atopic dermatitis
Anne-Sofie Halling, Maria Rasmussen Rinnov, Iben Frier Ruge, et al.
Seminars in Arthritis and Rheumatism
|
February 20, 2022
Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries
Alexander Egeberg, Nana Aviaaja Lippert Rosenø, David Aagaard, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Clinical and Experimental Dermatology
|
March 25, 2026
Changes in Drug Survival of Adalimumab Over Time in Patients with Psoriasis - A Nationwide Cohort Study
Gustav Hjort, Christopher W Schwarz, Lars E Bryld, et al.
International Journal of Molecular Sciences
|
April 13, 2023
Blood Cell Biomarkers of Inflammation and Cytokine Levels as Predictors of Response to Biologics in Patients with Psoriasis
Clara Sophie Bramsen Andersen, Amanda Kvist-Hansen, Mie Siewertsen, et al.
The Journal of Infectious Diseases
|
September 13, 2022
Incidence, Risk Factors, and Consequences of Human Alphaherpesvirus Infections in Patients With Psoriasis Who Initiate Methotrexate or Biologic Agents
Omid Rezahosseini, Mie Sylow Liljendahl, Nikolai Loft, et al.
JAMA Dermatology
|
January 7, 2026
Drug Survival of Biologics in Bionaive and Bioexperienced Patients With Psoriasis
Christopher Willy Schwarz, Nikolai Loft, Lars Erik Bryld, et al.
American Journal of Clinical Dermatology
|
March 5, 2025
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis
Amalie Thorsti Møller Rønnstad, Christopher G Bunick, Raj Chovatiya, et al.
American Journal of Clinical Dermatology
|
November 26, 2025
Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis
Amalie Thorsti Møller Rønnstad, Daniel Isufi, Christopher G Bunick, et al.
Acta Dermato-Venereologica
|
August 18, 2025
Adverse Events and Immune Response in Psoriasis Patients Receiving Interleukin-17 Inhibitors
Christopher Willy Schwarz, Charlotte Näslund-Koch, Claus Zachariae, et al.
Journal of the American Academy of Dermatology
|
November 30, 2020
Bidirectional association between atopic dermatitis, conjunctivitis, and other ocular surface diseases: A systematic review and meta-analysis
Nina H Ravn, Zohra F Ahmadzay, Tine A Christensen, et al.
The Journal of Allergy and Clinical Immunology
|
December 26, 2022
Skin TARC/CCL17 increase precedes the development of childhood atopic dermatitis
Anne-Sofie Halling, Maria Rasmussen Rinnov, Iben Frier Ruge, et al.
Seminars in Arthritis and Rheumatism
|
February 20, 2022
Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries
Alexander Egeberg, Nana Aviaaja Lippert Rosenø, David Aagaard, et al.
Page
of 4